Raymond D. Harris

435 total citations
9 papers, 347 citations indexed

About

Raymond D. Harris is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Raymond D. Harris has authored 9 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Raymond D. Harris's work include Virus-based gene therapy research (7 papers), CAR-T cell therapy research (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Raymond D. Harris is often cited by papers focused on Virus-based gene therapy research (7 papers), CAR-T cell therapy research (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Raymond D. Harris collaborates with scholars based in United States, Finland and France. Raymond D. Harris's co-authors include Ronald D. Alvarez, David T. Curiel, Rosemarie Aurigemma, Gene P. Siegal, Souheil Saddekni, Minghui Wang, Kenneth H. Kim, Meredith A. Preuss, Igor P. Dmitriev and M. L. Edwards and has published in prestigious journals such as Clinical Cancer Research, Virology and Molecular Pharmacology.

In The Last Decade

Raymond D. Harris

9 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raymond D. Harris United States 9 223 186 153 58 58 9 347
Elizabeth Davison United Kingdom 9 498 2.2× 367 2.0× 257 1.7× 23 0.4× 134 2.3× 10 604
Masoumeh Bolandian Iran 4 80 0.4× 106 0.6× 85 0.6× 17 0.3× 70 1.2× 12 298
Sonia Wennier United States 11 230 1.0× 99 0.5× 136 0.9× 47 0.8× 68 1.2× 13 388
Alexa Frentzen United States 11 264 1.2× 113 0.6× 199 1.3× 116 2.0× 30 0.5× 16 364
Kristina Quade United Kingdom 10 238 1.1× 291 1.6× 89 0.6× 14 0.2× 35 0.6× 13 443
William Harriman United States 14 207 0.9× 399 2.1× 40 0.3× 47 0.8× 52 0.9× 25 639
Janet Lei-Rossmann United Kingdom 12 233 1.0× 143 0.8× 231 1.5× 57 1.0× 54 0.9× 19 396
Steve Loechel United States 10 196 0.9× 286 1.5× 71 0.5× 13 0.2× 22 0.4× 14 593
Andrew Hofacre United States 11 128 0.6× 130 0.7× 68 0.4× 5 0.1× 20 0.3× 11 360
Moritz Thran Germany 6 80 0.4× 247 1.3× 46 0.3× 9 0.2× 96 1.7× 7 361

Countries citing papers authored by Raymond D. Harris

Since Specialization
Citations

This map shows the geographic impact of Raymond D. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond D. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond D. Harris more than expected).

Fields of papers citing papers by Raymond D. Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond D. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond D. Harris. The network helps show where Raymond D. Harris may publish in the future.

Co-authorship network of co-authors of Raymond D. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond D. Harris. A scholar is included among the top collaborators of Raymond D. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond D. Harris. Raymond D. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kim, Kenneth H., Igor P. Dmitriev, Souheil Saddekni, et al.. (2013). A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer. Gynecologic Oncology. 130(3). 518–524. 70 indexed citations
2.
Kim, Kenneth H., Igor P. Dmitriev, Janis P. O’Malley, et al.. (2012). A Phase I Clinical Trial of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Patients with Recurrent Gynecologic Cancer. Clinical Cancer Research. 18(12). 3440–3451. 49 indexed citations
4.
Kimball, Kristopher J., Meredith A. Preuss, Mack N. Barnes, et al.. (2010). A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic Diseases. Clinical Cancer Research. 16(21). 5277–5287. 81 indexed citations
5.
Matthews, Kellie S., Patricia E. Noker, Sheila Grimes, et al.. (2009). Identifying the Safety Profile of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Anticipation of a Phase I Clinical Trial in Patients with Recurrent Ovarian Cancer. Clinical Cancer Research. 15(12). 4131–4137. 17 indexed citations
6.
Yang, Xiaoyi, Raymond D. Harris, Steven L. Giardina, et al.. (2008). Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay. Journal of Virological Methods. 155(1). 44–54. 24 indexed citations
7.
Белоусова, Н. В., Raymond D. Harris, Kurt R. Zinn, et al.. (2006). Circumventing Recombination Events Encountered with Production of a Clinical-Grade Adenoviral Vector with a Double-Expression Cassette. Molecular Pharmacology. 70(5). 1488–1493. 10 indexed citations
8.
Bertioli, David J., et al.. (1991). Transgenic Plants and Insect Cells Expressing the Coat Protein of Arabis Mosaic Virus Produce Empty Virus-like Particles. Journal of General Virology. 72(8). 1801–1809. 43 indexed citations
9.
Préhaud, Christophe, Raymond D. Harris, Vilmos Fülöp, et al.. (1990). Expression, characterization, and purification of a phosphorylated rabies nucleoprotein synthesized in insect cells by baculovirus vectors. Virology. 178(2). 486–497. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026